Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 50 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 56 | 2,163−7.6%/yr | −7.6%/yr | 3.10.9× | 7% | 2,560 in 2030+2.8%/yr |
| Lumbar fusion | 56 | 2,015−1.3%/yr | −1.3%/yr | 2.80.9× | 1% | 2,510 in 2030+3.8%/yr |
| Cervical fusion & disc arthroplasty | 31 | 1,151−3.6%/yr | −3.6%/yr | 1.61.0× | 4% | 1,220 in 2030+0.9%/yr |
| Kyphoplasty & vertebroplasty | 7 | 691−9%/yr | −9%/yr | 1.00.6× | 12% | 870 in 2030+3.9%/yr |
| SI joint fusion | 3 | 206+39%/yr | +39%/yr | 0.30.8× | 14% | 340 in 2030+8.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 212 | 49,045+6%/yr | +6%/yr | 68.60.6× | 32% | 64,600 in 2030+4.7%/yr |
| Skin substitutes & wound grafts | 44 | 8,777+14%/yr | +14%/yr | 8.40.8× | 72% | 16,300 in 2030+11%/yr |
| Bone graft & orthobiologics | 13 | 440−13%/yr | −13%/yr | 0.60.9× | 1% | 450 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 107 | 7,768−1.3%/yr | −1.3%/yr | 10.90.8× | 87% | 8,970 in 2030+2.4%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 17 | 936+18%/yr | +18%/yr | 1.30.9× | 42% | 2,480 in 2030+18%/yr |
| Spinal cord & DRG stimulation | 21 | 702−4.7%/yr | −4.7%/yr | 1.01.0× | 36% | 710 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 30 | 3,370−11%/yr | −11%/yr | 5.10.9× | 29% | 3,610 in 2030+1.2%/yr |
| Peripheral arterial intervention | 19 | 2,514−4.5%/yr | −4.5%/yr | 3.50.5× | 25% | 3,310 in 2030+4.7%/yr |
| Superficial venous ablation | 27 | 1,612−7.3%/yr | −7.3%/yr | 2.30.4× | 96% | 1,950 in 2030+3.2%/yr |
| Thrombectomy, IVC filters & venous stents | 11 | 893+4.8%/yr | +4.8%/yr | 1.30.8× | 2% | 1,290 in 2030+6.4%/yr |
| Carotid revascularization | 14 | 710−8.3%/yr | −8.3%/yr | 1.00.8× | 0% | 840 in 2030+2.9%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 274−8.3%/yr | −8.3%/yr | 0.40.8× | 0% | 250 in 2030−1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 55 | 3,960−2.1%/yr | −2.1%/yr | 6.11.0× | 5% | 4,850 in 2030+3.4%/yr |
| Cholecystectomy & appendectomy | 65 | 2,781−5.5%/yr | −5.5%/yr | 4.20.9× | 1% | 3,300 in 2030+2.9%/yr |
| Colorectal resection | 6 | 1,082−4.9%/yr | −4.9%/yr | 1.60.9× | 0% | 1,180 in 2030+1.5%/yr |
| Antireflux & hiatal hernia surgery | 8 | 517+0.1%/yr | +0.1%/yr | 0.81.0× | 0% | 620 in 2030+3%/yr |
| Breast reconstruction | 1 | 295−3.4%/yr | −3.4%/yr | 0.40.9× | 0% | 360 in 2030+3.3%/yr |
| Bariatric surgery | 1 | 105−19%/yr | −19%/yr | 0.10.8× | 0% | 70 in 2030−5.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 83 | 4,214−0.8%/yr | −0.8%/yr | 6.21.2× | 7% | 4,820 in 2030+2.3%/yr |
| BPH procedures | 59 | 3,847−5.5%/yr | −5.5%/yr | 5.61.1× | 23% | 3,310 in 2030−2.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 21 | 1,697−2.4%/yr | −2.4%/yr | 2.50.9× | 15% | 2,220 in 2030+4.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 15 | 1,394−1.5%/yr | −1.5%/yr | 2.20.8× | 7% | 1,670 in 2030+3.1%/yr |
| Prostatectomy & nephrectomy | 12 | 808+1.4%/yr | +1.4%/yr | 1.31.0× | 0% | 1,300 in 2030+8.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 33 | 3,194−0.9%/yr | −0.9%/yr | 4.70.9× | 86% | 4,830 in 2030+7.1%/yr |
| Sleep apnea & airway implants | 8 | 218+73%/yr | +73%/yr | 0.31.3× | 0% | 400 in 2030+10%/yr |
| Cochlear implants | 6 | 142+4.7%/yr | +4.7%/yr | 0.21.3× | 17% | 310 in 2030+14%/yr |
| Ear tubes & middle ear surgery | 0 | 135−9.7%/yr | −9.7%/yr | 0.20.6× | 78% | 530 in 2030+26%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 68 | 3,858−2.4%/yr | −2.4%/yr | 6.00.9× | 11% | 4,310 in 2030+1.8%/yr |
| Tumor ablation | 2 | 220−0.1%/yr | −0.1%/yr | 0.31.0× | 0% | 260 in 2030+3.1%/yr |
| Tumor & fibroid embolization | 7 | 207−3.3%/yr | −3.3%/yr | 0.30.5× | 46% | 820 in 2030+26%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 108 | 17,936+27%/yr | +27%/yr | 25.80.9× | 93% | 35,200 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 68 | 3,818−0.9%/yr | −0.9%/yr | 5.81.0× | 1% | 4,480 in 2030+2.7%/yr |
| LAA occlusion & loop recorders | 71 | 3,614+14%/yr | +14%/yr | 4.71.3× | 11% | 6,460 in 2030+10%/yr |
| EP ablation | 41 | 3,270+9.7%/yr | +9.7%/yr | 4.11.1× | 0% | 6,810 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 103 | 4,333−4.9%/yr | −4.9%/yr | 5.30.9× | 0% | 4,970 in 2030+2.3%/yr |
| Structural heart (TAVR, TEER) | 56 | 1,406+10%/yr | +10%/yr | 1.81.1× | 0% | 2,380 in 2030+9.2%/yr |
| Mechanical circulatory support | 0 | 256−4.4%/yr | −4.4%/yr | 0.40.7× | 0% | 300 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 9 | 195−0.2%/yr | −0.2%/yr | 0.30.6× | 0% | 440 in 2030+15%/yr |
| Stroke thrombectomy | 7 | 160−8.2%/yr | −8.2%/yr | 0.20.5× | 0% | 250 in 2030+7.6%/yr |
| DBS & VNS | 2 | 151−3.2%/yr | −3.2%/yr | 0.20.7× | 0% | 260 in 2030+9.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 144 | 45,000+1.8%/yr | +1.8%/yr | 64.61.1× | 89% | 59,900 in 2030+4.9%/yr |
| Vitreoretinal surgery | 22 | 1,644−1.1%/yr | −1.1%/yr | 2.40.9× | 69% | 1,760 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 284 | 79,795−2.9%/yr | −2.9%/yr | 120.41.0× | 49% | 89,900 in 2030+2%/yr |
| ERCP & endoscopic ultrasound | 38 | 2,414+3.9%/yr | +3.9%/yr | 3.61.1× | 1% | 3,510 in 2030+6.4%/yr |
| Bronchoscopy & lung nodule | 29 | 1,874+3.7%/yr | +3.7%/yr | 2.80.8× | 0% | 3,150 in 2030+9%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.